251 related articles for article (PubMed ID: 26654222)
1. Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product.
Chen Y; Feng T; Li Y; Du B; Weng W
Pharm Dev Technol; 2017 Mar; 22(2):168-172. PubMed ID: 26654222
[TBL] [Abstract][Full Text] [Related]
2. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
4. A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study.
Teaima MH; Abdel-Haleem KM; Osama R; El-Nabarawi MA; Elnahas OS
Drug Des Devel Ther; 2021; 15():4229-4242. PubMed ID: 34675486
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y
Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method.
Zaid AN; Abualhasan MN; Watson DG; Mousa A; Ghazal N; Bustami R
Drug Des Devel Ther; 2015; 9():5315-21. PubMed ID: 26451086
[TBL] [Abstract][Full Text] [Related]
7. Novel montelukast sodium-loaded stable oral suspension bioequivalent to the commercial granules in rats.
Kim DW; Kim YH; Yousaf AM; Kim DS; Kwon TK; Park JH; Kim YI; Park JH; Jin SG; Kim KS; Cho KH; Li DX; Kim JO; Yong CS; Woo JS; Choi HG
Arch Pharm Res; 2016 Apr; 39(4):539-546. PubMed ID: 26983932
[TBL] [Abstract][Full Text] [Related]
8. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
[TBL] [Abstract][Full Text] [Related]
9. Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods.
Kashiwagura Y; Takusagawa S; Ikematsu Y; Tanaka S; Namiki N; Uchida S
Acta Pharm; 2023 Mar; 73(1):107-119. PubMed ID: 36692467
[TBL] [Abstract][Full Text] [Related]
10. Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance Part 2: Dissolution of Montelukast Sodium and Mesalazine Formulations.
Martir J; Flanagan T; Mann J; Fotaki N
AAPS PharmSciTech; 2020 Oct; 21(7):287. PubMed ID: 33063245
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation method].
Kawano Y; Ito A; Sasatsu M; Machida Y; Onishi H
Yakugaku Zasshi; 2010 Dec; 130(12):1737-42. PubMed ID: 21139401
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Predictive Dissolution Testing of Montelukast Sodium Formulations Administered with Drinks and Soft Foods to Infants.
Martir J; Flanagan T; Mann J; Fotaki N
AAPS PharmSciTech; 2020 Oct; 21(7):282. PubMed ID: 33051713
[TBL] [Abstract][Full Text] [Related]
13. Early patient experiences with montelukast orally disintegrating tablets in Japan: a cross-sectional survey of treatment satisfaction in patients with asthma and/or allergic rhinitis.
Whalley D; Petigara T; Rasouliyan L; Tobe K; Tunceli K
Curr Med Res Opin; 2017 Feb; 33(2):215-223. PubMed ID: 27764975
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
Gulsun T; Ozturk N; Kaynak MS; Vural I; Sahin S
Pharmazie; 2017 Jul; 72(7):389-394. PubMed ID: 29441935
[TBL] [Abstract][Full Text] [Related]
15. Co-processed chitin-mannitol as a new excipient for Oro-dispersible tablets.
Daraghmeh N; Chowdhry BZ; Leharne SA; Al Omari MM; Badwan AA
Mar Drugs; 2015 Mar; 13(4):1739-64. PubMed ID: 25830680
[TBL] [Abstract][Full Text] [Related]
16. Geriatric-Oriented High Dose Nutraceutical ODTs: Formulation and Physicomechanical Characterization.
Agiba AM; Abdel-Hamid S; Nasr M; Geneidi AS
Curr Drug Deliv; 2018 Feb; 15(2):267-277. PubMed ID: 28322163
[TBL] [Abstract][Full Text] [Related]
17. Performance Evaluation of Montelukast Pediatric Formulations: Part I-Age-Related In Vitro Conditions.
Guimarães M; Somville P; Vertzoni M; Fotaki N
AAPS J; 2022 Jan; 24(1):26. PubMed ID: 35013835
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of novel multi-channel orally disintegrating tablets.
Yu J; Shan X; Chen S; Sun X; Song P; Zhao R; Hu L
Eur J Pharm Sci; 2020 Jan; 142():105108. PubMed ID: 31669391
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs).
Woyna-Orlewicz K; Brniak W; Tatara W; Strzebońska M; Haznar-Garbacz D; Szafraniec-Szczęsny J; Antosik-Rogóż A; Wojteczko K; Strózik M; Kurek M; Jachowicz R; Mendyk A
Pharm Res; 2023 Dec; 40(12):2947-2962. PubMed ID: 37726407
[TBL] [Abstract][Full Text] [Related]
20. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
Dehghani H; Taheri A; Homayouni A
Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
